Active Pharmaceutical Ingredient (API) Market (2011-2016): Trends, Competitive Landscape and Global Forecasts, Market Research Report: MarketsandMarkets. Anesthesia Drugs Market 2011-2015, U.S. Ketamine Market Research Report :MarketsandMarkets. In-Vitro Diagnostics (IVD) Market: Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture – Global Trends & Forecasts to 2016, Market Research Report :MarketsandMarkets. Factors such as the continuous technological advancements in the field of diagnostics and an increase in healthcare awareness have made In Vitro Diagnostic testing an indispensable tool in current medical practices.
In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017. The advancements in molecular techniques, increasing awareness and acceptance of personalized medicines, rise in the occurrence of chronic diseases, and the need for the diagnosis of such diseases at early stages are the key factors driving the growth of the molecular diagnostics market. Biosimulation Market & Insilico Technology Research Report - Forecasts 2012-17.
The biosimulation market is expected to reach USD 2,107.99 Million by 2020 from USD 1,034.93 Million in 2015, at a CAGR of 15.29%.
Biosimulation refers to the modeling and simulation of complex biological processes and systems to understand their functions and physiologies at the molecular level. Biosimulation is used for target identification & validation, lead discovery & optimization, preclinical testing and clinical trials. This market report studies the potential of biosimulation software and services in drug discovery and development. The major drivers for the biosimulation market include the strong trend of R&D investments in biotechnology and pharmaceutical industries; the need to curtail drug discovery & development costs; growth in the biologics and biosimilars market; increased use of personalized medicines; technological advancements; and the trend of periodic product upgradation.
Autologous Stem Cell Market & Non-stem Cell Therapy Market - Forecasts 2012-17. This research report titled “Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017)” provides details about various autologous cell based treatments and their application areas.
Every health regulatory bodies will be expecting companies and universities to develop therapy treatments, which are Safer, Affordable, Robust, Rapid, Easy to use, Effective and Deliverable to the end user. Autologous stem cell transplantation for particular application areas is safe experiencing robust growth and has minimal steps of procedure to follow and is rapid in deriving the results. The sources for autologous stem cell therapy are Mesenchymal stem cells, Hematopoietic stem cells, Chondrocytes and so on.
Smart Pill Technology Market, Digital Pills, Capsule Endoscopy Market Size, Forecasts 2012-17. The global smart pills market is segmented on the basis of applications and regions.
The market by applications is categorized into capsule endoscopy, drug delivery, and patient monitoring. On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America). Factors such as favorable reimbursement scenario, patient preference for minimally invasive procedures, technological advancements in endoscopy procedures, and rising prevalence of colon cancer are driving the growth of this market.
Moreover, benefits provided by the smart pills technology such as technological advancements in endoscopy procedures, targeted drug delivery, and easy remote patient monitoring are propelling the adoption of this technology. Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Report - Forecasts 2012-17. The research analysis titled “Isothermal Nucleic Acid (Gene) Amplification Technologies (INAAT)” discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale.
The World Health Organization (WHO) proposes that, an ideal diagnostic test (DNA test kits, RNA test kit etc) that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end-user (ASSURED). Nucleic acid diagnostics targeting pathogen markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of affordability, rapidity, and being equipment free. In brief, this research report provides: It is worthy to mention that INAAT existed in parallel with PCR and yet its market potential was never exploited to the extent of PCR. Advanced Wound Care Market Research Report, Global Forecasts to 2016 :MarketsandMarkets.
Table of Contents 1 Introduction (Page No. - 24) 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2 Research Methodology (Page No. - 27) 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.2.1 Bottom-Up Approach 2.2.2 Top-Down Approach 2.3 Market Breakdown & Data Triangulation 2.4 Assumptions for the Study 3 Executive Summary (Page No. - 35) 4 Premium Insights (Page No. - 40) 4.1 Wound Care: Market Overview 4.2 Geographic Analysis: Wound Care Market, By Chronic Wounds (2017) 4.3 Wound Care Market, By Product, 2017–2022 4.4 Geographical Snapshot of the Wound Care Market *Top 25 Companies Analysed for This Study are - Acelity L.P.
List of Tables (356 Tables) List of Figures (50 Figures) Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications) (2012 - 2017) The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64%.
Epigenetics is defined as the study of the heritable changes in gene expression, without any changes to the main DNA sequence. In other words, epigenetics refers to covalent modification of DNA, RNA, or protein. High prevalence of cancer; increasing R & D funding; increasing intensity of research activities; increasing application for non-oncology diseases; and growing partnership between academic, biotechnology and pharmaceutical companies are driving factors of the epigenetics market.